Company Renalytix Plc Nasdaq

Equities

RNLX

US75973T1016

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Ratings for Renalytix Plc

Quarterly revenue - Rate of surprise

Sector Medical Diagnostic & Testing Equipment

Real-time Estimate Cboe BZX Other stock markets 16:23:04 15/05/2024 BST			5-day change	1st Jan Change
0.596 ^USD	-10.38%		-6.40%	+53.85%

01:15pm	Earnings Flash (RNLX) RENALYTIX Reports Q3 Revenue $535,000	MT
04-18	Renalytix chief business officer to become president	AN

Renalytix plc is a United Kingdom-based company, which is engaged in the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The Company is engaged in a field of bioprognosis for kidney health. The Company has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. The Companyâs lead product, KidneyIntelX platform, is designed to scale across kidney disease conditions beyond diabetic kidney disease. It is evaluating a range of indications in chronic kidney disease, cardio-renal disease, chronic kidney disease in diverse populations and COVID-related kidney disease. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Number of employees: 102

GBP in Million	2022	Weight	2023	Weight	Delta
Artificial Intelligence-enabled in Vitro Diagnostics 100.0 %	2	100.0 %	3	100.0 %	+26.61%

GBP in Million	2022	Weight	2023	Weight	Delta
United Kingdom 100.0 %	2	100.0 %	3	100.0 %	+26.61%

Managers	Title	Age	Since
James McCullough FOU	Founder	56	14/03/18
James Sterling DFI	Director of Finance/CFO	54	14/03/18
Howard Doran PSD	President	63	31/08/23
Fergus Fleming CTO	Chief Tech/Sci/R&D Officer	57	14/03/18
Michael Donovan CTO	Chief Tech/Sci/R&D Officer	70	14/03/18
Joseph Hutson PRN	Corporate Officer/Principal	-	21/07/21
Andria Parks-Herrera SAM	Sales & Marketing	-	06/06/21
Salim Hamir SEC	Corporate Secretary	-	-
Jed Fulk SAM	Sales & Marketing	64	06/10/21

Members of the board	Title	Age	Since
Daniel Levangie BRD	Director/Board Member	73	29/08/21
Christopher Mills CHM	Chairman	72	14/03/18
James McCullough FOU	Founder	56	14/03/18
Fergus Fleming CTO	Chief Tech/Sci/R&D Officer	57	14/03/18
Erik Lium BRD	Director/Board Member	56	31/10/18
Catherine Coste BRD	Director/Board Member	58	29/06/23

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	154,368,191	99,307,151 ( 64.33 %)	0	64.33 %

Name	Equities	%	Valuation
The Mount Sinai Hospital 18.80 %	23,979,726	18.80 %	6 M $
Polar Capital LLP 10.87 %	13,866,061	10.87 %	4 M $
Christopher Mills 7.897 %	10,072,500	7.897 %	3 M $
Jefferson River Capital LLC 6.690 %	8,533,280	6.690 %	2 M $
Heights Capital Management, Inc. 5.099 %	6,503,384	5.099 %	2 M $
Susquehanna Investment Group LLC 4.970 %	6,339,906	4.970 %	2 M $
Pentwater Capital Management LP 4.536 %	5,785,196	4.536 %	2 M $
Nathaniel Rothschild 4.503 %	5,743,476	4.503 %	2 M $
Lombard Odier Asset Management (Europe) Ltd. 3.136 %	4,000,000	3.136 %	1 M $
Harwood Capital LLP 2.195 %	2,800,000	2.195 %	753 788 $

Name	Equities	%	Valuation
Jefferson River Capital LLC 6.690 %	4,266,640	6.690 %	3 M $
Pentwater Capital Management LP 1.976 %	1,260,000	1.976 %	786 240 $
Gilder, Gagnon, Howe & Co. LLC 1.379 %	879,451	1.379 %	548 777 $
Pentwater Capital Management LP 1.098 %	700,000	1.098 %	436 800 $
Pinnacle Associates Ltd. 1.091 %	696,005	1.091 %	434 307 $
Stifel Independent Advisors LLC 0.8756 %	558,400	0.8756 %	348 442 $
Tejara Capital Ltd. 0.7846 %	500,394	0.7846 %	312 246 $
Corient Private Wealth LLC 0.5261 %	335,514	0.5261 %	209 361 $
Gofen & Glossberg LLC 0.2951 %	188,224	0.2951 %	117 452 $
Lazard Asset Management LLC 0.1967 %	125,478	0.1967 %	78 298 $

Renalytix Plc

1460 Broadway

10036, New York

+646 397 3970

http://www.renalytixai.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.245

Average target price

Consensus

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
SARTORIUS AG	-12.27%	19.25B
QUIDELORTHO CORPORATION	-38.13%	2.96B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+23.79%	1.96B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-0.62%	1.69B
BIOTAGE AB	+32.69%	1.27B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-16.17%	982M
CONTEC MEDICAL SYSTEMS CO.,LTD	-20.31%	913M
REVENIO GROUP OYJ	+5.45%	801M
VAREX IMAGING CORPORATION	-24.44%	630M

Medical Diagnostic & Testing Equipment